Michael Maes Selected Research

Chemokines

1/2023	In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
3/2021	Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments.
1/2021	The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
9/2020	CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders.
3/2020	The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study.
2/2020	The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia.
1/2019	Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients.
5/2018	Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Maes Research Topics

Disease

74	Schizophrenia (Dementia Praecox) 05/2023 - 04/2002
70	Inflammation (Inflammations) 11/2023 - 09/2002
43	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 04/2024 - 10/2005
41	Fatigue 11/2023 - 10/2006
34	Psychotic Disorders (Schizoaffective Disorder) 11/2023 - 01/2004
33	Major Depressive Disorder (Major Depressive Disorders) 02/2024 - 01/2014
33	Bipolar Disorder (Manic Depressive Psychosis) 10/2023 - 09/2002
31	Mood Disorders (Mood Disorder) 04/2023 - 11/2003
26	Depressive Disorder (Melancholia) 10/2022 - 02/2005
23	Infections 05/2023 - 10/2003
17	Cognitive Dysfunction 04/2024 - 02/2012
15	Medically Unexplained Symptoms 01/2023 - 02/2012
15	Mental Disorders (Mental Disorder) 11/2022 - 12/2002
14	COVID-19 02/2024 - 12/2020
14	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 12/2012
13	Insulin Resistance 04/2024 - 11/2014
13	Multiple Sclerosis 05/2020 - 01/2011
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2011
12	Pain (Aches) 02/2024 - 10/2006
12	Fibromyalgia (Fibrositis) 01/2023 - 12/2013
12	Neoplasms (Cancer) 01/2023 - 02/2002
12	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2014
11	Autism Spectrum Disorder 03/2024 - 01/2018
11	Neuroinflammatory Diseases 01/2022 - 11/2012
10	Autistic Disorder (Autism) 01/2021 - 01/2002
10	Parkinson Disease (Parkinson's Disease) 01/2021 - 12/2013
9	Tobacco Use Disorder (Nicotine Dependence) 11/2021 - 06/2014
8	Post-Acute COVID-19 Syndrome 04/2024 - 01/2022
8	Obesity 02/2024 - 01/2011
8	Anxiety Disorders (Anxiety Disorder) 01/2024 - 12/2012
8	Necrosis 01/2021 - 12/2002
7	Stroke (Strokes) 01/2024 - 01/2011
7	Wounds and Injuries (Trauma) 01/2023 - 08/2010
6	Ischemic Stroke 01/2023 - 01/2019
6	Treatment-Resistant Depressive Disorder 04/2022 - 02/2004

Drug/Important Bio-Agent (IBA)

84	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2012
61	CytokinesIBA 03/2024 - 01/2002
60	Tryptophan (L-Tryptophan)FDA Link 11/2023 - 09/2002
40	Immunoglobulin M (IgM)IBA 04/2024 - 10/2003
40	AntioxidantsIBA 10/2023 - 10/2006
34	Immunoglobulin A (IgA)IBA 04/2024 - 04/2007
32	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2002
26	Antidepressive Agents (Antidepressants)IBA 04/2024 - 12/2002
22	Interleukin-6 (Interleukin 6)IBA 05/2023 - 12/2002
20	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022 - 12/2002
19	InterleukinsIBA 11/2023 - 02/2005
19	ZincIBA 11/2023 - 12/2005
18	Interleukin-10 (Interleukin 10)IBA 01/2023 - 12/2002
17	Aryldialkylphosphatase (Paraoxonase)IBA 01/2023 - 04/2014
17	Malondialdehyde (Propanedial)IBA 01/2023 - 04/2011
16	C-Reactive ProteinIBA 04/2024 - 04/2011
15	LipidsIBA 01/2024 - 10/2006
15	CalciumIBA 11/2023 - 03/2017
15	KynurenineIBA 11/2023 - 09/2002
15	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 03/2005
13	Advanced Oxidation Protein Products (AOPP)IBA 04/2024 - 11/2017
11	EpitopesIBA 01/2024 - 02/2012
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 02/2012
10	HDL CholesterolIBA 01/2024 - 04/2014
10	EnzymesIBA 10/2022 - 12/2007
10	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2022 - 12/2005
10	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 04/2011
10	AntibodiesIBA 10/2019 - 03/2003
9	MagnesiumIBA 12/2022 - 12/2012
9	Fatty Acids (Saturated Fatty Acids)IBA 08/2022 - 05/2004
9	Polytetrafluoroethylene (Teflon)FDA Link 10/2021 - 10/2014
9	HaptoglobinsIBA 01/2021 - 03/2005
9	Glutathione (Reduced Glutathione)IBA 01/2021 - 04/2011
8	Immunoglobulin G (IgG)IBA 04/2024 - 03/2003
8	Interleukin-17 (Interleukin 17)IBA 01/2024 - 10/2015
8	ChemokinesIBA 01/2023 - 05/2018
8	AlbuminsIBA 01/2023 - 10/2016
8	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023 - 04/2011
8	Opioid Analgesics (Opioids)IBA 12/2022 - 01/2019
8	InterferonsIBA 01/2022 - 02/2005
8	Antipsychotic Agents (Antipsychotics)IBA 10/2021 - 04/2002
8	Uric Acid (Urate)IBA 10/2020 - 07/2015
8	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 01/2009
8	NeopterinIBA 12/2012 - 07/2003
7	Messenger RNA (mRNA)IBA 04/2024 - 05/2012
7	CholesterolIBA 01/2024 - 05/2004
7	LipopolysaccharidesIBA 01/2024 - 02/2004
7	oxidized low density lipoproteinIBA 11/2022 - 09/2010
7	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 11/2014
7	HDL LipoproteinsIBA 01/2021 - 04/2014
7	MelatoninIBA 03/2017 - 06/2012
6	Hormones (Hormone)IBA 04/2024 - 10/2005
6	Minocycline (Cyclops)FDA LinkGeneric 02/2024 - 12/2014
6	Interleukin-1 (Interleukin 1)IBA 01/2024 - 02/2012
6	AntigensIBA 01/2024 - 01/2013
6	CateninsIBA 01/2024 - 08/2019
6	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2023 - 01/2019
6	Peroxidase (Myeloperoxidase)IBA 05/2023 - 10/2020
6	Insulin (Novolin)FDA Link 05/2023 - 11/2014
6	Fluoxetine (Prozac)FDA LinkGeneric 01/2023 - 02/2004
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 01/2004
6	CopperIBA 01/2023 - 03/2021
6	HMGB1 Protein (HMG1)IBA 11/2022 - 10/2020
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2022 - 04/2011

Therapy/Procedure

12	Therapeutics 04/2022 - 01/2004